Epidemiological investigation of the first 5685 cases of SARS-CoV-2 infection in Qatar, 28 February–18 April 2020

Autor: Abdul-Badi Abou-Samra, Robert Owen, Laith J Abu-Raddad, Hanan M Al Kuwari, Hanan F Abdul Rahim, Zaina Al Kanaani, Abdullatif Al Khal, Einas Al Kuwari, Salih Al Marri, Muna Al Masalmani, Hamad E Al Romaihi, Mohamed H Al Thani, Peter V Coyle, Ali N Latif, Roberto Bertollini, Adeel Ajwad Butt

Publikováno v: BMJ Open, Vol 10, Iss 10 (2020)

Objective To define the epidemiological curve of COVID-19 in Qatar and determine factors associated with severe or critical illness.Design Case series of first 5685 COVID-19 cases in Qatar.Setting and participants All confirmed COVID-19 cases in the

Externí odkaz: https://doaj.org/article/9a7e2976b61f4849a570b129926c4d5e

Bivalent mRNA-1273.214 vaccine effectiveness against SARS-CoV-2 omicron XBB* infections

Autor: Hiam Chemaitelly, Houssein H. Ayoub, Sawsan AlMukdad, Jeremy Samuel Faust, Patrick Tang, Peter Coyle, HADI M. YASSINE, Asmaa Althani, Hebah A. Al-Khatib, Mohammad R. Hasan, Zaina Al-Kanaani, Einas Al-Kuwari, Andrew Jeremijenko, Anvar H. Kaleeckal, Ali N. Latif, Riyazuddin M. Shaik, Hanan F. Abdul-Rahim, Gheyath Nasrallah, Mohamed G. Al-Kuwari, Adeel A Butt, Hamad Eid Al-Romaihi, Mohammed H. Al-Thani, Abdullatif Al-Khal, Roberto Bertollini, Laith J Abu-Raddad

Qatar introduced COVID-19 bivalent vaccination for persons ≥12 years old using the 50-μg mRNA-1273.214 vaccine combining SARS-CoV-2 ancestral and omicron BA.1 strains. We estimated effectiveness of this bivalent vaccine against SARS-CoV-2 infectio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f729d32d8794226ff980e45d2de191a0
https://doi.org/10.1101/2023.04.15.23288612

Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar

Autor: Laith J. Abu-Raddad, Hiam Chemaitelly, Houssein H. Ayoub, Sawsan AlMukdad, Hadi M. Yassine, Hebah A. Al-Khatib, Maria K. Smatti, Patrick Tang, Mohammad R. Hasan, Peter Coyle, Zaina Al-Kanaani, Einas Al-Kuwari, Andrew Jeremijenko, Anvar H. Kaleeckal, Ali N. Latif, Riyazuddin M. Shaik, Hanan F. Abdul-Rahim, Gheyath K. Nasrallah, Mohamed Ghaith Al-Kuwari, Adeel A. Butt, Hamad Eid Al-Romaihi, Mohamed H. Al-Thani, Abdullatif Al-Khal, Roberto Bertollini

Publikováno v: Abu-Raddad, L J, Chemaitelly, H, Ayoub, H H, AlMukdad, S, Yassine, H M, Al-Khatib, H A, Smatti, M K, Tang, P, Hasan, M R, Coyle, P, Al-Kanaani, Z, Al-Kuwari, E, Jeremijenko, A, Kaleeckal, A H, Latif, A N, Shaik, R M, Abdul-Rahim, H F, Nasrallah, G K, Al-Kuwari, M G, Butt, A A, Al-Romaihi, H E, Al-Thani, M H, Al-Khal, A & Bertollini, R 2022, ' Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar ', New England Journal of Medicine . https://doi.org/10.1056/NEJMoa2200797

Waning of vaccine protection against coronavirus disease 2019 (Covid-19) and the emergence of the omicron (or B.1.1.529) variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have led to expedited efforts to scale up booster vac

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd047bd093503d562332cedb721b08ad
https://doi.org/10.1056/nejmoa2200797

Protective Effect of Previous SARS-CoV-2 Infection against Omicron BA.4 and BA.5 Subvariants

Autor: Heba N. Altarawneh, Hiam Chemaitelly, Houssein H. Ayoub, Mohammad R. Hasan, Peter Coyle, Hadi M. Yassine, Hebah A. Al-Khatib, Maria K. Smatti, Zaina Al-Kanaani, Einas Al-Kuwari, Andrew Jeremijenko, Anvar H. Kaleeckal, Ali N. Latif, Riyazuddin M. Shaik, Hanan F. Abdul-Rahim, Gheyath K. Nasrallah, Mohamed G. Al-Kuwari, Adeel A. Butt, Hamad E. Al-Romaihi, Mohamed H. Al-Thani, Abdullatif Al-Khal, Roberto Bertollini, Patrick Tang, Laith J. Abu-Raddad

Publikováno v: The New England journal of medicine. 387(17)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1346162eee05a04aaa6f3ed4a3b73f64
https://pubmed.ncbi.nlm.nih.gov/36198139

Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections

Autor: Heba N. Altarawneh, Hiam Chemaitelly, Houssein H. Ayoub, Patrick Tang, Mohammad R. Hasan, Hadi M. Yassine, Hebah A. Al-Khatib, Maria K. Smatti, Peter Coyle, Zaina Al-Kanaani, Einas Al-Kuwari, Andrew Jeremijenko, Anvar H. Kaleeckal, Ali N. Latif, Riyazuddin M. Shaik, Hanan F. Abdul-Rahim, Gheyath K. Nasrallah, Mohamed G. Al-Kuwari, Adeel A. Butt, Hamad E. Al-Romaihi, Mohamed H. Al-Thani, Abdullatif Al-Khal, Roberto Bertollini, Laith J. Abu-Raddad

Publikováno v: The New England journal of medicine. 387(1)

The protection conferred by natural immunity, vaccination, and both against symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection with the BA.1 or BA.2 sublineages of the omicron (B.1.1.529) variant is unclear. We conduct

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1f7a3bcabc8756ecaaaf5cf6274c1be
https://pubmed.ncbi.nlm.nih.gov/35704396